APO Research
Talk to an analyst

APO RESEARCH · REPORT

Strep Throat Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Strep Throat Treatment Drugs Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchStrep Throat Treatment Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Strep Throat Treatment Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Strep Throat Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Strep Throat Treatment Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Strep Throat Treatment Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Strep Throat Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Strep Throat Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Strep Throat Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Strep Throat Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Strep Throat Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Strep Throat Treatment Drugs include Johnson & Johnson, Novartis, Merck & co., Roche, Eli Lily, Pfizer, Bayer, Bristol-Myers Squibb and Astra Zeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Strep Throat Treatment Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Strep Throat Treatment Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Strep Throat Treatment Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Strep Throat Treatment Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Strep Throat Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Strep Throat Treatment Drugs revenue, projected growth trends, production technology, application and end-user industry.

Strep Throat Treatment Drugs Segment by Company

Johnson & Johnson

Novartis

Merck & co.

Roche

Eli Lily

Pfizer

Bayer

Bristol-Myers Squibb

Astra Zeneca

Bausch Health

Abbott Laboratories

Strep Throat Treatment Drugs Segment by Type

Penicillin

Amoxicillin

Strep Throat Treatment Drugs Segment by Application

Specialty Clinics

Diagnostic Laboratories

Hospitals

Strep Throat Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Strep Throat Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Strep Throat Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Strep Throat Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Strep Throat Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Strep Throat Treatment Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Strep Throat Treatment Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Strep Throat Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Penicillin Major Player Table 3. Amoxicillin Major Player Table 4. Global Strep Throat Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Specialty Clinics Major Player Table 6. Diagnostic Laboratories Major Player Table 7. Hospitals Major Player Table 8. Strep Throat Treatment Drugs Industry Trends Table 9. Strep Throat Treatment Drugs Industry Drivers Table 10. Strep Throat Treatment Drugs Industry Opportunities and Challenges Table 11. Strep Throat Treatment Drugs Industry Restraints Table 12. Global Strep Throat Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Strep Throat Treatment Drugs Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Strep Throat Treatment Drugs Market Share by Region (2021-2026) Table 15. Global Strep Throat Treatment Drugs Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Strep Throat Treatment Drugs Market Share by Region (2027-2032) Table 17. Global Strep Throat Treatment Drugs Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Strep Throat Treatment Drugs Revenue Market Share by Players (2021-2026) Table 19. Global Strep Throat Treatment Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Strep Throat Treatment Drugs Key Players Headquarters & Area Served Table 21. Global Strep Throat Treatment Drugs Players, Product Type & Application Table 22. Global Strep Throat Treatment Drugs Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Strep Throat Treatment Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Strep Throat Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Strep Throat Treatment Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Strep Throat Treatment Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Strep Throat Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Strep Throat Treatment Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Strep Throat Treatment Drugs Revenue Market Share by Application (2027-2032) Table 35. Johnson & Johnson Company Information Table 36. Johnson & Johnson Business Overview Table 37. Johnson & Johnson Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Johnson & Johnson Strep Throat Treatment Drugs Product Portfolio Table 39. Johnson & Johnson Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Strep Throat Treatment Drugs Product Portfolio Table 44. Novartis Recent Development Table 45. Merck & co. Company Information Table 46. Merck & co. Business Overview Table 47. Merck & co. Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck & co. Strep Throat Treatment Drugs Product Portfolio Table 49. Merck & co. Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Roche Strep Throat Treatment Drugs Product Portfolio Table 54. Roche Recent Development Table 55. Eli Lily Company Information Table 56. Eli Lily Business Overview Table 57. Eli Lily Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Eli Lily Strep Throat Treatment Drugs Product Portfolio Table 59. Eli Lily Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer Strep Throat Treatment Drugs Product Portfolio Table 64. Pfizer Recent Development Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Bayer Strep Throat Treatment Drugs Product Portfolio Table 69. Bayer Recent Development Table 70. Bristol-Myers Squibb Company Information Table 71. Bristol-Myers Squibb Business Overview Table 72. Bristol-Myers Squibb Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bristol-Myers Squibb Strep Throat Treatment Drugs Product Portfolio Table 74. Bristol-Myers Squibb Recent Development Table 75. Astra Zeneca Company Information Table 76. Astra Zeneca Business Overview Table 77. Astra Zeneca Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Astra Zeneca Strep Throat Treatment Drugs Product Portfolio Table 79. Astra Zeneca Recent Development Table 80. Bausch Health Company Information Table 81. Bausch Health Business Overview Table 82. Bausch Health Strep Throat Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Bausch Health Strep Throat Treatment Drugs Product Portfolio Table 84. Bausch Health Recent Development Table 85. Abbott Laboratories Company Information Table 86. Abbott Laboratories Business Overview Table 87. Abbott Laboratories Strep Throat Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Abbott Laboratories Strep Throat Treatment Drugs Product Portfolio Table 89. Abbott Laboratories Recent Development Table 90. North America Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Strep Throat Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Strep Throat Treatment Drugs Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Strep Throat Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Strep Throat Treatment Drugs Revenue by Country (US$ Million) & (2027-2032) Table 104. China Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 105. China Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 106. China Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 107. China Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Strep Throat Treatment Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Strep Throat Treatment Drugs Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Strep Throat Treatment Drugs Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Strep Throat Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Strep Throat Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Strep Throat Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Strep Throat Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Strep Throat Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Strep Throat Treatment Drugs Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Strep Throat Treatment Drugs Image Figure 2. Global Strep Throat Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Strep Throat Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Penicillin Image Figure 5. Amoxicillin Image Figure 6. Global Strep Throat Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Strep Throat Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Specialty Clinics Image Figure 9. Diagnostic Laboratories Image Figure 10. Hospitals Image Figure 11. Global Strep Throat Treatment Drugs Market Size (US$ Million) & (2021-2032) Figure 12. Global Strep Throat Treatment Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Strep Throat Treatment Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Strep Throat Treatment Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Strep Throat Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Strep Throat Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Strep Throat Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 19. Global Strep Throat Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Strep Throat Treatment Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Strep Throat Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Strep Throat Treatment Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Strep Throat Treatment Drugs Revenue Share by Type (2021-2032) Figure 24. North America Strep Throat Treatment Drugs Revenue Share by Application (2021-2032) Figure 25. North America Strep Throat Treatment Drugs Revenue Share by Country (2021-2032) Figure 26. United States Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Strep Throat Treatment Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Strep Throat Treatment Drugs Revenue Share by Type (2021-2032) Figure 31. Europe Strep Throat Treatment Drugs Revenue Share by Application (2021-2032) Figure 32. Europe Strep Throat Treatment Drugs Revenue Share by Country (2021-2032) Figure 33. Germany Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Strep Throat Treatment Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Strep Throat Treatment Drugs Revenue Share by Type (2021-2032) Figure 43. China Strep Throat Treatment Drugs Revenue Share by Application (2021-2032) Figure 44. Asia Strep Throat Treatment Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Strep Throat Treatment Drugs Revenue Share by Type (2021-2032) Figure 46. Asia Strep Throat Treatment Drugs Revenue Share by Application (2021-2032) Figure 47. Asia Strep Throat Treatment Drugs Revenue Share by Region (2021-2032) Figure 48. Japan Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Strep Throat Treatment Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Strep Throat Treatment Drugs Revenue Share by Type (2021-2032) Figure 56. SAMEA Strep Throat Treatment Drugs Revenue Share by Application (2021-2032) Figure 57. SAMEA Strep Throat Treatment Drugs Revenue Share by Country (2021-2032) Figure 58. Brazil Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Strep Throat Treatment Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Amoxicillin
Applications
  • Specialty Clinics
  • Diagnostic Laboratories
  • Hospitals
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck & co.
  • Roche
  • Eli Lily
  • Pfizer
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca
  • Bausch Health
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Strep Throat Treatment Drugs Market by Type
  3. 1.2.1 Global Strep Throat Treatment Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Penicillin
  5. 1.2.3 Amoxicillin
  6. 1.3 Strep Throat Treatment Drugs Market by Application
  7. 1.3.1 Global Strep Throat Treatment Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Specialty Clinics
  9. 1.3.3 Diagnostic Laboratories
  10. 1.3.4 Hospitals
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Strep Throat Treatment Drugs Market Dynamics
  1. 2.1 Strep Throat Treatment Drugs Industry Trends
  2. 2.2 Strep Throat Treatment Drugs Industry Drivers
  3. 2.3 Strep Throat Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Strep Throat Treatment Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Strep Throat Treatment Drugs Market Perspective (2021-2032)
  2. 3.2 Global Strep Throat Treatment Drugs Growth Trends by Region
  3. 3.2.1 Global Strep Throat Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Strep Throat Treatment Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Strep Throat Treatment Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Strep Throat Treatment Drugs Revenue by Players
  2. 4.1.1 Global Strep Throat Treatment Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Strep Throat Treatment Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Strep Throat Treatment Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Strep Throat Treatment Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Strep Throat Treatment Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Strep Throat Treatment Drugs Players, Product Type & Application
  8. 4.5 Global Strep Throat Treatment Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Strep Throat Treatment Drugs Market CR5 and HHI
  11. 4.6.3 2025 Strep Throat Treatment Drugs Tier 1, Tier 2, and Tier 3
5 Strep Throat Treatment Drugs Market Size by Type
  1. 5.1 Global Strep Throat Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Strep Throat Treatment Drugs Revenue Market Share by Type (2021-2032)
6 Strep Throat Treatment Drugs Market Size by Application
  1. 6.1 Global Strep Throat Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Strep Throat Treatment Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Strep Throat Treatment Drugs Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Strep Throat Treatment Drugs Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck & co.
  14. 7.3.1 Merck & co. Company Information
  15. 7.3.2 Merck & co. Business Overview
  16. 7.3.3 Merck & co. Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck & co. Strep Throat Treatment Drugs Product Portfolio
  18. 7.3.5 Merck & co. Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche Strep Throat Treatment Drugs Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Eli Lily
  26. 7.5.1 Eli Lily Company Information
  27. 7.5.2 Eli Lily Business Overview
  28. 7.5.3 Eli Lily Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lily Strep Throat Treatment Drugs Product Portfolio
  30. 7.5.5 Eli Lily Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Strep Throat Treatment Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Bayer
  38. 7.7.1 Bayer Company Information
  39. 7.7.2 Bayer Business Overview
  40. 7.7.3 Bayer Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bayer Strep Throat Treatment Drugs Product Portfolio
  42. 7.7.5 Bayer Recent Developments
  43. 7.8 Bristol-Myers Squibb
  44. 7.8.1 Bristol-Myers Squibb Company Information
  45. 7.8.2 Bristol-Myers Squibb Business Overview
  46. 7.8.3 Bristol-Myers Squibb Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bristol-Myers Squibb Strep Throat Treatment Drugs Product Portfolio
  48. 7.8.5 Bristol-Myers Squibb Recent Developments
  49. 7.9 Astra Zeneca
  50. 7.9.1 Astra Zeneca Company Information
  51. 7.9.2 Astra Zeneca Business Overview
  52. 7.9.3 Astra Zeneca Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Astra Zeneca Strep Throat Treatment Drugs Product Portfolio
  54. 7.9.5 Astra Zeneca Recent Developments
  55. 7.10 Bausch Health
  56. 7.10.1 Bausch Health Company Information
  57. 7.10.2 Bausch Health Business Overview
  58. 7.10.3 Bausch Health Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bausch Health Strep Throat Treatment Drugs Product Portfolio
  60. 7.10.5 Bausch Health Recent Developments
  61. 7.11 Abbott Laboratories
  62. 7.11.1 Abbott Laboratories Company Information
  63. 7.11.2 Abbott Laboratories Business Overview
  64. 7.11.3 Abbott Laboratories Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abbott Laboratories Strep Throat Treatment Drugs Product Portfolio
  66. 7.11.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Strep Throat Treatment Drugs Revenue (2021-2032)
  2. 8.2 North America Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Strep Throat Treatment Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Strep Throat Treatment Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Strep Throat Treatment Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Strep Throat Treatment Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Strep Throat Treatment Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Strep Throat Treatment Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Strep Throat Treatment Drugs Revenue by Country
  11. 8.6.1 North America Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Strep Throat Treatment Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Strep Throat Treatment Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Strep Throat Treatment Drugs Revenue (2021-2032)
  2. 9.2 Europe Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Strep Throat Treatment Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Strep Throat Treatment Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Strep Throat Treatment Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Strep Throat Treatment Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Strep Throat Treatment Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Strep Throat Treatment Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Strep Throat Treatment Drugs Revenue by Country
  11. 9.6.1 Europe Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Strep Throat Treatment Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Strep Throat Treatment Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Strep Throat Treatment Drugs Revenue (2021-2032)
  2. 10.2 China Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Strep Throat Treatment Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Strep Throat Treatment Drugs Revenue by Type (2027-2032)
  5. 10.3 China Strep Throat Treatment Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Strep Throat Treatment Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Strep Throat Treatment Drugs Revenue by Application (2027-2032)
  9. 10.5 China Strep Throat Treatment Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Strep Throat Treatment Drugs Revenue (2021-2032)
  2. 11.2 Asia Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Strep Throat Treatment Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Strep Throat Treatment Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Strep Throat Treatment Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Strep Throat Treatment Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Strep Throat Treatment Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Strep Throat Treatment Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Strep Throat Treatment Drugs Revenue by Country
  11. 11.6.1 Asia Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Strep Throat Treatment Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Strep Throat Treatment Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Strep Throat Treatment Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Strep Throat Treatment Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Strep Throat Treatment Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Strep Throat Treatment Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Strep Throat Treatment Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Strep Throat Treatment Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Strep Throat Treatment Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Strep Throat Treatment Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Strep Throat Treatment Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Strep Throat Treatment Drugs Revenue by Country
  11. 12.6.1 SAMEA Strep Throat Treatment Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Strep Throat Treatment Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Strep Throat Treatment Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst